Humanization of the AβPP sequence and implementation of three targeted mutations (NL-Swedish, G-Arctic, and F-Beyreuther/Iberian) generates distinct amyloidosis that resembles human AD and simulates aspects of neuroinflammation (Saito and Saido, 2018). Here, APP is linked to Alzheimer disease.